Raymond James on Legend Biotech Corp. (LEGN): 'the dataset suggests very strong efficacy with room for improvement on safety'
Raymond James analyst Sean McCutcheon reiterated an Outperform rating and $86.00 price target on Legend Biotech Corp. (NASDAQ: LEGN).The analyst ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)